Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
|Articles|October 2, 2019
- Pharmaceutical Technology-10-02-2019
- Volume 43
- Issue 10
Multi-Shaft Mixers for High-Quality Gels and Creams
VersaMix Multi-Shaft Mixers from Ross utilize a proprietary powder induction feature for charging of thickeners to produce high-quality gels, creams, and pastes.
VersaMix Multi-Shaft Mixers from Ross utilize a proprietary powder induction feature for charging of thickeners to produce high-quality gels, creams, and pastes. The mixer comes equipped with a three-winged anchor, a high-speed disperser blade that provides combinations of shear and bulk flow at various stages of the mixing cycle, and a rotor/stator emulsifying head that highlights the Solids/Liquid Injection Manifold (SLIM) Technology for sub-surface raw material additions.
Available in laboratory and productions sizes up to 2000 gallons, the mixer features lubricant-free shaft seals, an 11-inch touch screen, and a recipe system for batching based on speed, time, temperature, and vacuum level.
Articles in this issue
almost 7 years ago
FT-IR Spectrometeralmost 7 years ago
Nexera Prep Seriesalmost 7 years ago
Pharmaceutical Cleanroom Monitoringalmost 7 years ago
Stability Testing for Small-Molecule Clinical Trial Materialsalmost 7 years ago
Image Repair Must Get to the Root Causealmost 7 years ago
The Never-Ending Brexit?almost 7 years ago
Out with the Old and In with the New European Commissionalmost 7 years ago
Data Integrity Violations Draw Strong FDA Rebukesalmost 7 years ago
The Fundamentals of Dissolution Testingalmost 7 years ago
Overcoming Bioavailability ‘Roadblocks’ with LBDDSRelated to this article
This article discusses risk-based lifecycle governance, system implementation considerations, and the progression of batch record control from paper-based to fully electronic systems.
Ronald Piervincenzi, USP, explains why manufacturers should act now and how benchmarking could reward reliable generic drug suppliers.
The FDA approves Lilly's once-weekly insulin efsitora for type 2 diabetes, raising Fc-fusion manufacturing, high-concentration pen, and capacity questions.
Florin Muraru, Gourav Pandey, and Richard Jaenisch explain where human sign-off belongs as multi-agent AI and document-parsing models reach GxP.
In this episode of Ask the Expert, Siegfried Schmitt, PhD, vice president, Technical at Parexel, and Susan J. Schniepp, distinguished fellow at Nelson Labs, discuss how companies should approach post-approval changes to their CMC regulatory filings.
The EC has approved AstraZeneca's Trixeo Aerosphere as the first single-inhaler triple-combination therapy for asthma in the EU, based on phase e data showing improved lung function and fewer severe exacerbations in patients uncontrolled on standard ICS/LABA treatment.
In this episode of Pharma Fundamentals, Dr. Aleksandra Zuraw, senior veterinary pathologist at Charles River, provides an introduction to the use of digital pathology in drug development.
Trending on Pharmaceutical Technology
1
Risk-Based Life Cycle Management of Master Production and Control Records to Strengthen Data Integrity and GMP Inspection Readiness Part 2: Practical Considerations for CGMP Documentation Systems
2
CPHI Milan: USP Benchmarks Reshape Procurement Incentives
3
The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push
4
PharmTech’s Weekly Roundup—September 25, 2026
5